Trastuzumab Deruxtecan Biosimilar - Research Grade
Product Specifications
Background
Trastuzumab deruxtecan is a HER2-targeting ADC structurally composed of a humanized anti-HER2 antibody, enzymatically cleavable peptide-linker, and a novel topoisomerase I inhibitor (DXd), which is cell-membrane permeable and more potent than SN-38 the active metabolite of irinotecan.
Product Name Alternative
Dxd
Host
CHO Cells
Reactivity
Human
Target
ERBB2 / HER2 / CD340
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6147448-01 0.1 mL
GPR89 (G-Protein-coupled Receptor 89A, GPR89A, GPR89B, CGI-13, FLJ10492, FLJ11696, FLJ36909, FLJ79270, Golgi pH Regulator A, GPHRA, MGC688, MGC87324, Protein GPR89A, Putative MAPK-activating Protein PM01, Putative NF-kappa-B-activating Protein 90, SH120,
Sign In for Pricing
View Details 
MBS6147448-02 5x 0.1 mL
GPR89 (G-Protein-coupled Receptor 89A, GPR89A, GPR89B, CGI-13, FLJ10492, FLJ11696, FLJ36909, FLJ79270, Golgi pH Regulator A, GPHRA, MGC688, MGC87324, Protein GPR89A, Putative MAPK-activating Protein PM01, Putative NF-kappa-B-activating Protein 90, SH120,
Sign In for Pricing
View Details 
HY-W011895-01 1 g
Tert-Butyl (6-aminohexyl) carbamate hydrochloride
Sign In for Pricing
View Details HY-W011895-02 5 g
Tert-Butyl (6-aminohexyl) carbamate hydrochloride
Sign In for Pricing
View Details